{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:36:30Z","timestamp":1792643790761,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/mop.0b013e328355b248","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T10:36:34Z","timestamp":1342002994000},"page":"480-486","source":"Crossref","is-referenced-by-count":47,"title":["Childhood mastocytosis"],"prefix":"10.1097","volume":"24","author":[{"given":"Antonio","family":"Torrelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Alvarez-Twose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210206","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1600-0625.2009.00860.x","article-title":"Mast cells: novel clinical perspectives from recent insights.","volume":"18","author":"Kneilling","year":"2009","journal-title":"Exp Dermatol"},{"key":"R2-9-20210206","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","article-title":"Recent advances in the understanding of mastocytosis: the role of KIT mutations.","volume":"138","author":"Orfao","year":"2007","journal-title":"Br J Haematol"},{"key":"R3-9-20210206","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients.","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"R4-9-20210206","doi-asserted-by":"crossref","first-page":"e1906","DOI":"10.1371\/journal.pone.0001906","article-title":"Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.","volume":"3","author":"Lanternier","year":"2008","journal-title":"PLoS One"},{"key":"R5-9-20210206","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","article-title":"One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes.","volume":"162","author":"Sotlar","year":"2003","journal-title":"Am J Pathol"},{"key":"R6-9-20210206","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1525-1578(10)60552-1","article-title":"c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation.","volume":"7","author":"Yanagihori","year":"2005","journal-title":"J Mol Diagn"},{"key":"R7-9-20210206","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.","volume":"130","author":"Bodemer","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R8-9-20210206","first-page":"695","article-title":"Mastocytosis: an update.","volume":"8","author":"Amon","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"R9-9-20210206","first-page":"320","article-title":"Pediatric cutaneous mastocytosis: a review of 180 patients.","volume":"7","author":"Ben-Amitai","year":"2005","journal-title":"Isr Med Assoc J"},{"key":"R10-9-20210206","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1525-1470.2002.00110.x","article-title":"Mastocytosis in childhood.","volume":"19","author":"Heide","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"R11-9-20210206","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","article-title":"Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis.","volume":"67","author":"Alvarez-Twose","year":"2012","journal-title":"Allergy"},{"key":"R12-9-20210206","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2230.2008.03005.x","article-title":"Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.","volume":"34","author":"Heide","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R13-9-20210206","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"R14-9-20210206","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.","volume":"128","author":"Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"R15-9-20210206","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1067\/mjd.2003.98","article-title":"Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology.","volume":"48","author":"Brockow","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R16-9-20210206","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R17-9-20210206","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4049\/jimmunol.138.7.2184","article-title":"Evaluation of human peripheral blood leukocytes for mast cell tryptase.","volume":"138","author":"Castells","year":"1987","journal-title":"J Immunol"},{"key":"R18-9-20210206","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1074\/jbc.274.6.3355","article-title":"Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.","volume":"274","author":"Pallaoro","year":"1999","journal-title":"Biol Chem"},{"key":"R19-9-20210206","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.4049\/jimmunol.164.12.6566","article-title":"Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.","volume":"164","author":"Caughey","year":"2000","journal-title":"J Immunol"},{"key":"R20-9-20210206","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","article-title":"The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.","volume":"96","author":"Schwartz","year":"1995","journal-title":"J Clin Invest"},{"key":"R21-9-20210206","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM198706253162603","article-title":"Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.","volume":"316","author":"Schwartz","year":"1987","journal-title":"N Engl J Med"},{"key":"R22-9-20210206","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11882-006-0061-0","article-title":"Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.","volume":"6","author":"Akin","year":"2006","journal-title":"Curr Allergy Asthma Rep"},{"key":"R23-9-20210206","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOH.0b013e3283366c59","article-title":"Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.","volume":"17","author":"Pardanani","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"R24-9-20210206","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ajh.23459","article-title":"Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.","volume":"87","author":"Pardanani","year":"2012","journal-title":"Am J Hematol"},{"key":"R25-9-20210206","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal.","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"R26-9-20210206","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/modpathol.2008.141","article-title":"Utility of the World Health Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow.","volume":"22","author":"Johnson","year":"2009","journal-title":"Mod Pathol"},{"key":"R27-9-20210206","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications.","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"R28-9-20210206","first-page":"1493","article-title":"Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration.","volume":"149","author":"Orfao","year":"1996","journal-title":"Am J Pathol"},{"key":"R29-9-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","article-title":"Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).","volume":"58","author":"Escribano","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"key":"R30-9-20210206","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0145-2126(01)00050-9","article-title":"Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis.","volume":"25","author":"Escribano","year":"2001","journal-title":"Leuk Res"},{"key":"R31-9-20210206","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10428190400010775","article-title":"Mastocytosis: pathology, genetics, and current options for therapy.","volume":"46","author":"Valent","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R32-9-20210206","first-page":"516","article-title":"Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.","volume":"25","author":"Morgado","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"R33-9-20210206","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib.","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"R34-9-20210206","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.10.020","article-title":"Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.","volume":"125","author":"Teodosio","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R36-9-20210206","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/modpathol.2011.84","article-title":"Evaluation of the WHO criteria for the classification of patients with mastocytosis.","volume":"24","author":"Sanchez-Munoz","year":"2011","journal-title":"Mod Pathol"},{"key":"R37-9-20210206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000243808","article-title":"Clinical aspects of diffuse cutaneous mastocytosis in children: two variants.","volume":"219","author":"Heide","year":"2009","journal-title":"Dermatology"},{"key":"R38-9-20210206","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1525-1470.1994.tb00560.x","article-title":"Urticaria pigmentosa: a review of 67 pediatric cases.","volume":"11","author":"Azana","year":"1994","journal-title":"Pediatr Dermatol"},{"key":"R39-9-20210206","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.22125","article-title":"Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology.","volume":"53","author":"Uzzaman","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R40-9-20210206","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/archderm.1996.03890360013002","article-title":"Diffuse cutaneous mastocytosis. Treatment with oral psoralen plus UV-A.","volume":"132","author":"Mackey","year":"1996","journal-title":"Arch Dermatol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e328355b248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T18:19:08Z","timestamp":1714155548000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201208000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e328355b248","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}